Vitamin D to Improve Quadricep Muscle Strength
Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether vitamin D supplements can help improve muscle strength in people who have had surgery for an anterior cruciate ligament (ACL) injury. After ACL reconstruction, many patients experience a decrease in the strength of their quadriceps muscle, which is crucial for getting back to sports and daily activities. The researchers want to find out if taking vitamin D can help these patients regain muscle strength and overcome any vitamin D deficiency, which is common among athletes.
To participate in the trial, you must be between 18 and 40 years old, have had a single ACL injury, and still have low vitamin D levels even four months after your surgery. Additionally, your quadriceps strength should be less than 70% compared to the other leg. If you join the trial, you will receive either vitamin D supplements or a placebo (a non-active pill), and your muscle strength will be monitored to see if the vitamin D helps. It's important to note that this study is looking for ways to help patients recover better after ACL surgery and possibly prevent long-term muscle weakness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-40 with unilateral ACL injury
- • 2. Sporting injury with a Tegner score of 7
- • 3. Pre-op serum vitamin D level \<20 ng/ml
- • 4. 4 months post-ACLR with serum Vitamin D level remained \<20ng/ml
- • 5. LSI for quadriceps strength \<70% of contralateral leg at 4-month isokinetic assessment
- • 6. Both knees without history of injury/prior surgery
- Exclusion Criteria:
- • 1. Concomitant bone fracture, major meniscus injury or full-thickness chondral injuries requiring altered rehabilitation program post-operatively
- • 2. Pre-operative radiographic signs of arthritis
- • 3. Metal implants that would cause interference on MRI
- • 4. Non-HS graft for ACLR
- • 5. Patient non-compliant to the rehabilitation program
- • 6. Regular sunbed users
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials